PASADENA, Calif. — A study among Kaiser Permanente members in Southern California shows that allowing patients to self-order a colorectal cancer screening test online improves rates of testing completion. The rates of both completion and follow-up activities were higher among patients who ordered the tests themselves than those who received the test kit automatically in the mail when it was due, per the usual process.
The research was published today in the Journal of General Internal Medicine.
“The colorectal cancer screening rates among Kaiser Permanente members in Southern California are already over 80% due to dedicated efforts by our clinical and operational teams,” said lead researcher Erin Hahn, PhD, MPH, of the Kaiser Permanente Southern California Department of Research & Evaluation. “However, we are always striving to improve, and we found that offering self-ordering on our secure kp.org website seemed to increase a patient’s commitment to taking and sending in the test. This was very gratifying because we know these tests can save lives.”
Colorectal cancer is one of the leading causes of cancer-related death in the United States, with more than 50,000 deaths estimated in 2019. If we can increase our colorectal cancer screening rates even by a little, we could have an enormous impact on reducing colorectal cancer mortality, Dr. Hahn said.
In the study, researchers evaluated the interactive interface on the kp.org website that allowed patients who were due for an at-home colorectal cancer screening kit to self-order — in this case fecal immunochemical test kits — with the click of a button. For those who did not self-order online, kits were automatically mailed to them when they were due to take the test.
Kaiser Permanente recommends annual at-home colorectal cancer screening for patients between the ages of 50 and 74 years of age, who have had no history of colorectal cancer, have not completed colorectal cancer screening within the past 12 months, and have not completed a colonoscopy within the past 10 years, or sigmoidoscopy within the past 5 years.
The study cohort included 176,231 participants between 50 and 74 years of age who were eligible for colorectal cancer screening. It found:
“Based on these results, we see that it is possible that the self-order option can act as an effective commitment device,” Dr. Hahn said. “This may be the case even for patients who had not previously completed a colorectal screening test.”
For 75 years, Kaiser Permanente has been committed to shaping the future of health and health care — and helping our members, patients, and communities experience more healthy years. We are recognized as one of America’s leading health care providers and not-for-profit health plans. Since July 21, 1945, Kaiser Permanente’s mission has been to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve 12.4 million members in 8 states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal Permanente Medical Group physicians, specialists, and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery, and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education, and the support of community health.